Fionnuala McAleese Eser

Antibody Lead Discovery 1
Bayer AG
Fionnuala McAleese Eser
Fionnuala received her PhD (Microbiology) from Trinity College Dublin in 2002. Her post-doctoral studies were carried out at Wyeth Pharmaceuticals (NY) where she worked on S. aureus antibiotic resistance mechanisms. She then transferred to the Global Biologics organization at Wyeth (Cambridge, MA; acquired by Pfizer in 2009) as a Senior Scientist working primarily with phage display in the antibody lead discovery department with a focus on cancer, inflammatory and infectious diseases. In 2010, she moved to Heidelberg Germany in a role as Head of Antibody Lead Discovery for Affimed, generating bispecific NK and T-cell engagers for the treatment of cancer. Since 2013, Fionnuala has been a Group Leader in the Antibody Lead Discovery department within Biologics Research at Bayer with a primary focus on biotherapeutic discovery for cardiovascular indications (Cologne, Germany).

Sessions

No data was found

Download Brochure

Full details regarding the Biologics Series are available for download in the Conference Brochure